Key Manufacturers in the Migraine Drugs Market
Top manufacturers in the migraine drugs market focus heavily on research and development. Pfizer’s nasal spray, Zavzpret, provides a new treatment option for acute migraines, while AbbVie’s Qulipta has shown promising results compared to traditional treatments.
Companies are also adopting digital health tools to improve patient engagement and adherence. Collaborations and partnerships are increasing, helping companies expand their product lines and reach more patients.
FAQ:Q1: What is Zavzpret?A1: A nasal spray by Pfizer for acute migraine treatment.
Q2: How does Qulipta compare to traditional therapies?A2: It demonstrates better outcomes and fewer treatment discontinuations.
Q3: How are companies expanding their reach?A3: Through partnerships, collaborations, and digital solutions.